Related Experiment Video

Updated: May 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K

Utilizing proton therapy to reduce health-care disparities among patients with breast cancers

Kristin Hsieh1,2, Jehee Isabelle Choi2,3, Anthony Nehlsen1,2

  • 1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.

JNCI Cancer Spectrum
|February 25, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.6K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.2K

Related Experiment Videos

Last Updated: May 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.6K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

Articles linked to this work by shared authors, journal, and citation graph.

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.

Nature communications·2026

International Consensus Guidelines for Radiation Target Volume Delineation for Skull Base Chordoma-A Particle Therapy Co-operative Group Initiative.

International journal of radiation oncology, biology, physics·2026

Novel Bragg peak FLASH radiotherapy: treatment of base-of-skull tumors within existing clinical guidelines.

Frontiers in oncology·2026

Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma.

International journal of cancer·2026

Tissue-Informed ctDNA Assay Performance in Head and Neck Squamous Cell Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026

Proton Therapy for Muscle-Invasive Bladder Cancer: Outcomes from the Multicenter Proton Collaborative Group PCG 001-09 Registry Trial.

Cureus·2026

Platform-Agnostic Quantification for Molecular Interception of Oral and Esophageal Malignancies: A Global Study Addressing Diagnostic Divide.

JNCI cancer spectrum·2026

Swedish matched-cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer-risk.

JNCI cancer spectrum·2026

Evaluating a shared decision engagement system in the NCI community oncology research program: a multi-level RCT.

JNCI cancer spectrum·2026

Genetic and cellular architecture of breast cancer risk across ancestries.

JNCI cancer spectrum·2026

Early-onset blood cancer risks associated with living near superfund sites.

JNCI cancer spectrum·2026

Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer.

JNCI cancer spectrum·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us